Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

This study has been completed.
Information provided by (Responsible Party):
Centre Antoine Lacassagne Identifier:
First received: April 18, 2009
Last updated: February 8, 2015
Last verified: February 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)